Diseases, Conditions, Syndromes

Romosozumab increases bone mineral density post-menopause

(HealthDay)—Romosozumab seems safe and effective for increasing bone mineral density in postmenopausal women with low bone mineral density, according to a study published online Jan. 1 in the New England Journal of Medicine.

Diseases, Conditions, Syndromes

Alendronate reduces adjacent-level vertebral fractures

(HealthDay)—For females with osteoporosis, the rate of adjacent-level vertebral fractures is relatively low, with reduced odds with bisphosphonate therapy, according to a study published in the Dec. 1 issue of Spine.

Diseases, Conditions, Syndromes

Osteoporosis drugs compared for side effects, efficacy

A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic ...

Diseases, Conditions, Syndromes

Not just a 'women's disease,' osteoporosis strikes men too

Osteoporosis, a disease that causes bones to weaken and sometimes break, is often thought of as a "women's disease," but it poses a significant threat to more than 2 million men in the United States, according to the National ...

Health

Building stronger bones one runner at a time

(Medical Xpress)—Helping others avoid the broken bones she had as a teenager motivated Wake Forest senior Aubrey Bledsoe to work with a health and exercise science professor to study bone health in athletes.

page 19 from 31